In survey experiments, should all covariates be administered before the experimental treatment? Some scholars argue that post-treatment items should never be used as covariates because the treatment could bias the measurement of those items and disrupt experimental randomization. Other scholars argue certain items—specifically sensitive questions measuring prejudice—should not be administered pre-treatment. They argue if asked pre-treatment, these items may prime respondents in ways that will influence how they engage with the experiment treatment, thereby affecting the overall outcome of the experiment. Using evidence from four studies (two original collections) that vary the placement of sensitive items—pre-treatment, post-treatment, or in a separate wave—we find little evidence that the placement of sensitive items influences the measurement of those items, the experimental outcomes, nor heterogeneously affects the outcome conditional on the treatment. However, we find the placement of sensitive items inconsistently affects the experimental outcome by interacting with both the measurement of the items and the experimental treatment condition. Overall, we find these measures to be robust to where they are administered. It may be best to place items pre-treatment to preserve randomization. If researchers have reason to include sensitive moderators post-treatment, they should transparently discuss this choice and the anticipated trade-offs.